Healio spoke with Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, who is the global principal investigator for the BREATHE-3 trial, which treated its first patient in August. This multicenter, randomized, interventional, controlled, phase 3 trial hopes to determine the safety and impact of a novel bronchoscopic device on lung function in adults with severe COPD-related emphysema and hyperinflation.
IMPORTANT: As of 8:00 AM on September 3, Temple University Hospital – Main Campus (Broad and Ontario Streets) will no longer provide Labor and Delivery services. All childbirth services will be relocated to our new hospital location.
TRANSIT ALERT: Major cuts to bus, subway, and rail may affect travel to and from our campuses. Read full update.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH